搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
Medindia
2 小时
Cipla Gets Green Light from CDSCO for Inhaled Insulin
Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...
3 天
Cipla’s ‘inhaled insulin’ from US’ MannKind Corp adds a ‘layer of convenience ...
Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.
money.rediff
4 天
Cipla Gets Nod for Insulin Inhalation Powder: Afrezza
Cipla secures CDSCO approval for Afrezza, a rapid-acting insulin delivered through an inhaler, offering a convenient solution ...
4 天
Cipla to bring in inhaled insulin Afrezza from US’ MannKind Corporation
Cipla receives approval to market Afrezza, a rapid-acting insulin inhaler, offering a needle-free solution for diabetes ...
ThePrint on MSN
2 天
Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025
Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...
4 天
Cipla gets CDSCO nod to launch inhalation insulin
Cipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, ...
4 天
Cipla gets CDSCO nod to market insulin inhalation powder for diabetes management
Taken at the beginning of a meal, the medication dissolves rapidly upon oral inhalation into the lungs and delivers insulin ...
4 天
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India
India has the 2nd highest burden of diabetes worldwideCDSCO decision follows existing approvals in the U.S.A. and ...
The Financial Express
4 天
CDSCO gives nod to Cipla for distribution and marketing of inhaled insulin in India
This is the first and only non- injectable insulin to be developed for patients of both type 1 and type 2 diabetes mellitus.
4 天
Cipla gets approval to market Afrezza insulin inhalation powder in India
Drug maker Cipla on Wednesday said it has received approval from the Central Drugs Standard Control Organisation for the ...
punjabnewsexpress
4 天
CDSCO approves Cipla to distribute, market inhaled insulin in India
Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market ...
The Economic Times on MSN
3 天
Cipla shares in focus after receiving CDSCO nod to launch inhalation insulin
Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈